Skip to main content

Infectious Diseases

Featured Article

PharmLaw
10/21/2026
Grace Taylor, MS, MA
An Illinois laboratory owner faces federal wire fraud charges for allegedly submitting $66.2 million in fraudulent COVID-19 testing claims, including hundreds of thousands of tests that were never performed.
An Illinois laboratory owner faces federal wire fraud charges for allegedly submitting $66.2 million in fraudulent COVID-19 testing claims, including hundreds of thousands of tests that were never performed.
An Illinois laboratory owner...
10/21/2026
Pharmacy Learning Network
Quiz
09/22/2023
At what age do nearly all children in the US become infected with RSV?
At what age do nearly all children in the US become infected with RSV?
At what age do nearly all...
09/22/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
01/19/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In light of new research and the ongoing evolution of the SARS-CoV-2 virus, Dr Jennings reviews efficacy data on 2 non-antiviral drugs for the treatment of patients with COVID-19.
In light of new research and the ongoing evolution of the SARS-CoV-2 virus, Dr Jennings reviews efficacy data on 2 non-antiviral drugs for the treatment of patients with COVID-19.
In light of new research and the...
01/19/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
11/23/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the Omicron subvariants BQ.1 and BQ.1.1.
Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the Omicron subvariants BQ.1 and BQ.1.1.
Dr Jennings shares new guidance...
11/23/2022
Pharmacy Learning Network
Videos
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Interview
04/19/2021
Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test works, and details what this newly developed...
Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test works, and details what this newly developed...
Sudeb Dalai, MD, PhD, senior...
04/19/2021
Pharmacy Learning Network
Talking Therapeutics
03/03/2021
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In the first installment, Dr Jennings breaks down the COVID-19 vaccines, and explains how to discuss them with patients.
In the first installment, Dr Jennings breaks down the COVID-19 vaccines, and explains how to discuss them with patients.
In the first installment, Dr...
03/03/2021
Pharmacy Learning Network
News
02/25/2021
Health organizations have begun sending doctors and nurses to apartment buildings and private homes to vaccinate homebound older adults, but the efforts are slow and spotty.
Health organizations have begun sending doctors and nurses to apartment buildings and private homes to vaccinate homebound older adults, but the efforts are slow and spotty.
Health organizations have begun...
02/25/2021
Pharmacy Learning Network
Interview
02/24/2021
Adnan Iqbal, CEO and co-founder, Luma Health, identifies what is lacking in vaccine delivery and operations, and offers tips for health administrators and health systems that are looking to improve their vaccine rollout.
Adnan Iqbal, CEO and co-founder, Luma Health, identifies what is lacking in vaccine delivery and operations, and offers tips for health administrators and health systems that are looking to improve their vaccine rollout.
Adnan Iqbal, CEO and co-founder,...
02/24/2021
Pharmacy Learning Network
Headshot of Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, on a dark blue background
Podcasts
02/03/2021
Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, American Society of Health-System Pharmacists, reviews the recently released data on both the Novavax and Johnson & Johnson COVID-19 vaccines, discusses how these vaccines...
Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, American Society of Health-System Pharmacists, reviews the recently released data on both the Novavax and Johnson & Johnson COVID-19 vaccines, discusses how these vaccines...
Michael Ganio, PharmD, senior...
02/03/2021
Pharmacy Learning Network

Newsfeed

PharmLaw
10/21/2026
Grace Taylor, MS, MA
An Illinois laboratory owner faces federal wire fraud charges for allegedly submitting $66.2 million in fraudulent COVID-19 testing claims, including hundreds of thousands of tests that were never performed.
An Illinois laboratory owner faces federal wire fraud charges for allegedly submitting $66.2 million in fraudulent COVID-19 testing claims, including hundreds of thousands of tests that were never performed.
An Illinois laboratory owner...
10/21/2026
Pharmacy Learning Network
News
01/13/2020
Authors of a new study evaluated the influenza vaccine’s effectiveness against laboratory-confirmed influenza-associated hospitalizations among older adults with COPD.
Authors of a new study evaluated the influenza vaccine’s effectiveness against laboratory-confirmed influenza-associated hospitalizations among older adults with COPD.
Authors of a new study evaluated...
01/13/2020
Pharmacy Learning Network
News
11/25/2019
Amanda Balbi
“Understanding barriers to influenza vaccination can help the development of interventions to reduce influenza vaccine hesitancy, increase vaccination, and reduce influenza burden,” researchers wrote.
“Understanding barriers to influenza vaccination can help the development of interventions to reduce influenza vaccine hesitancy, increase vaccination, and reduce influenza burden,” researchers wrote.
“Understanding barriers to...
11/25/2019
Pharmacy Learning Network
News
10/28/2019
Amanda Balbi
“This study reveals that [people living with HIV] may be at a substantial disadvantage in terms of receiving correct statin therapy for ASCVD risk reduction,” the researchers concluded.
“This study reveals that [people living with HIV] may be at a substantial disadvantage in terms of receiving correct statin therapy for ASCVD risk reduction,” the researchers concluded.
“This study reveals that [people...
10/28/2019
Pharmacy Learning Network
News
09/11/2019
The American Thoracic Society has released a new clinical practice guideline on laboratory testing for the diagnosis of fungal infections in pulmonary and critical care practice.
The American Thoracic Society has released a new clinical practice guideline on laboratory testing for the diagnosis of fungal infections in pulmonary and critical care practice.
The American Thoracic Society...
09/11/2019
Pharmacy Learning Network
News
11/05/2026
Rebecca Amrick
ValuHealth extra strength acetaminophen is under a voluntary Class III recall after the product was incorrectly labeled, affecting 100 134 bottles.
ValuHealth extra strength acetaminophen is under a voluntary Class III recall after the product was incorrectly labeled, affecting 100 134 bottles.
ValuHealth extra strength...
11/05/2026
Pharmacy Learning Network
News
11/05/2026
Rebecca Amrick
A voluntary Class II recall has been issued for formoterol fumarate inhalation solution due to the product’s failure to meet impurities specifications, a discrepancy that affects 3210 cartons.
A voluntary Class II recall has been issued for formoterol fumarate inhalation solution due to the product’s failure to meet impurities specifications, a discrepancy that affects 3210 cartons.
A voluntary Class II recall has...
11/05/2026
Pharmacy Learning Network
News
11/05/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for metoclopramide tablets due to cross contamination with other tablets.
The US Food and Drug Administration (FDA) has issued a Class II recall for metoclopramide tablets due to cross contamination with other tablets.
The US Food and Drug...
11/05/2026
Pharmacy Learning Network
PharmLaw
11/04/2026
Hannah Musick
The US Department of Labor has finalized new transparency requirements for pharmacy benefit managers, mandating expanded compensation disclosures and audit provisions to strengthen employer health plan oversight and accountability under the...
The US Department of Labor has finalized new transparency requirements for pharmacy benefit managers, mandating expanded compensation disclosures and audit provisions to strengthen employer health plan oversight and accountability under the...
The US Department of Labor has...
11/04/2026
Pharmacy Learning Network
News
10/29/2026
Rebecca Amrick
Cinacalcet tablets are under a voluntary Class II recall due to the product’s failure to meet dissolution specifications, affecting 49 488 bottles.
Cinacalcet tablets are under a voluntary Class II recall due to the product’s failure to meet dissolution specifications, affecting 49 488 bottles.
Cinacalcet tablets are under a...
10/29/2026
Pharmacy Learning Network
News
10/29/2026
Rebecca Amrick
A voluntary Class II recall has been issued for heparin sodium injection due to the product’s lack of sterility assurance, affecting 251 000 vials.
A voluntary Class II recall has been issued for heparin sodium injection due to the product’s lack of sterility assurance, affecting 251 000 vials.
A voluntary Class II recall has...
10/29/2026
Pharmacy Learning Network
News
10/29/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for Abirtega (abiraterone acetate) after the tablets failed to meet weight uniformity specifications, affecting 2136 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for Abirtega (abiraterone acetate) after the tablets failed to meet weight uniformity specifications, affecting 2136 bottles.
The US Food and Drug...
10/29/2026
Pharmacy Learning Network
PharmLaw
10/28/2026
Grace Taylor, MS, MA
A Florida durable medical equipment company owner was convicted for her role in an $8.6 million Medicare fraud scheme involving falsified prescriptions, illegal kickbacks, and claims for medically unnecessary orthotic braces.
A Florida durable medical equipment company owner was convicted for her role in an $8.6 million Medicare fraud scheme involving falsified prescriptions, illegal kickbacks, and claims for medically unnecessary orthotic braces.
A Florida durable medical...
10/28/2026
Pharmacy Learning Network
News
10/22/2026
Rebecca Amrick
Sermorelin is under a voluntary Class II recall due to a lack of process control, affecting 7 vials.
Sermorelin is under a voluntary Class II recall due to a lack of process control, affecting 7 vials.
Sermorelin is under a voluntary...
10/22/2026
Pharmacy Learning Network
News
10/22/2026
Rebecca Amrick
A voluntary Class II recall has been issued for tirzepatide/niacinamide due to the product’s lack of sterility assurance, affecting 64 vials.
A voluntary Class II recall has been issued for tirzepatide/niacinamide due to the product’s lack of sterility assurance, affecting 64 vials.
A voluntary Class II recall has...
10/22/2026
Pharmacy Learning Network

Insights

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
01/19/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In light of new research and the ongoing evolution of the SARS-CoV-2 virus, Dr Jennings reviews efficacy data on 2 non-antiviral drugs for the treatment of patients with COVID-19.
In light of new research and the ongoing evolution of the SARS-CoV-2 virus, Dr Jennings reviews efficacy data on 2 non-antiviral drugs for the treatment of patients with COVID-19.
In light of new research and the...
01/19/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
11/23/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the Omicron subvariants BQ.1 and BQ.1.1.
Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the Omicron subvariants BQ.1 and BQ.1.1.
Dr Jennings shares new guidance...
11/23/2022
Pharmacy Learning Network
Videos
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Interview
04/19/2021
Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test works, and details what this newly developed...
Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test works, and details what this newly developed...
Sudeb Dalai, MD, PhD, senior...
04/19/2021
Pharmacy Learning Network
Talking Therapeutics
03/03/2021
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In the first installment, Dr Jennings breaks down the COVID-19 vaccines, and explains how to discuss them with patients.
In the first installment, Dr Jennings breaks down the COVID-19 vaccines, and explains how to discuss them with patients.
In the first installment, Dr...
03/03/2021
Pharmacy Learning Network
Headshot of Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, on a dark blue background
Podcasts
02/03/2021
Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, American Society of Health-System Pharmacists, reviews the recently released data on both the Novavax and Johnson & Johnson COVID-19 vaccines, discusses how these vaccines...
Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, American Society of Health-System Pharmacists, reviews the recently released data on both the Novavax and Johnson & Johnson COVID-19 vaccines, discusses how these vaccines...
Michael Ganio, PharmD, senior...
02/03/2021
Pharmacy Learning Network
Headshot of Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, on a dark blue background
Podcasts
01/21/2021
Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, discusses a video series that was recently created by the medical and health community for the medical and health community featuring physicians and nurses,...
Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, discusses a video series that was recently created by the medical and health community for the medical and health community featuring physicians and nurses,...
Valerie Montgomery Rice, MD,...
01/21/2021
Pharmacy Learning Network
Commentary
07/20/2020
“Together we will get through this challenging time in history and emerge stronger, healthier, wiser and hopefully even more grateful each day for the gift of life,” Yvette C Terrie, BS Pharm, RPh, expresses.
“Together we will get through this challenging time in history and emerge stronger, healthier, wiser and hopefully even more grateful each day for the gift of life,” Yvette C Terrie, BS Pharm, RPh, expresses.
“Together we will get through...
07/20/2020
Pharmacy Learning Network